Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Tognella

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Journal of Investigational Allergology & Clinical Immunology|January 25, 2019
Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life PerspectiveM Caminati, A Vianello, F Chieco Bianchi, et al.
British Journal of Cancer|September 2, 1999
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenograftsG Pratesi, P Perego, D Polizzi, et al.
BMC Pulmonary Medicine|August 27, 2016
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experienceM Caminati, G Senna, G Stefanizzi, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Journal of Investigational Allergology & Clinical Immunology|January 25, 2019
Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life PerspectiveM Caminati, A Vianello, F Chieco Bianchi, et al.
British Journal of Cancer|September 2, 1999
A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenograftsG Pratesi, P Perego, D Polizzi, et al.
BMC Pulmonary Medicine|August 27, 2016
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experienceM Caminati, G Senna, G Stefanizzi, et al.
Pageof 9